In the closing months of last year, the Food and Drug Administration sent warning letters to Olympus Medical Systems Corporation and its subsidiary Aizu Olympus over violations concerning medical device reporting (MDR) requirements and quality systems regulations for endoscopes and some endoscope accessories.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?